MarketLens

What Does Olumiant's EU Recommendation Mean for Eli Lilly

6 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Is the GLP-1 Price War Escalating, and What Does it Mean for Eli Lilly

6 months ago

What's Driving the Bearish Options Activity in Eli Lilly

6 months ago

Why Are Institutional Investors Still Bullish on Eli Lilly

5 months ago

Is Eli Lilly's Premium Valuation Justified by its Growth Story

6 months ago

Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s

Eli Lilly's immunology portfolio is gaining ground with steady revenue growth, pipeline expansion, and acquisitions, broadening its next wave of growth beyond GLP-1s.

GLP

Stock News•2 weeks ago

Eli Lilly Clears Big Hurdle in Alzheimer's Fight

Eli Lilly (LLY) cleared a key Alzheimer's hurdle after the FDA approved a new blood test developed with Roche, which could help identify patients earlier and expand treatment access.

LLY

Stock News•1 months ago

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

AbbVie's RINVOQ received EU approval for severe alopecia areata in adults and adolescents, after Phase 3 data showed statistically significant scalp hair regrowth at week 24.

ABBV

Breaking News

Clinical Trials (Phase I, II, III)

Creator Economy

Crude Oil (WTI/Brent)

Top Headlines

View More →

Stock News•2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News•2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News•3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News•4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News•6 hours ago

What Does Olumiant's EU Recommendation Mean for Eli Lilly

Exclusive Content for Pro Members

Related Articles

Is the GLP-1 Price War Escalating, and What Does it Mean for Eli Lilly

What's Driving the Bearish Options Activity in Eli Lilly

Why Are Institutional Investors Still Bullish on Eli Lilly

Is Eli Lilly's Premium Valuation Justified by its Growth Story

Category

You may also like

Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s

Eli Lilly Clears Big Hurdle in Alzheimer's Fight

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Viral AI Dommer Tweet: Engineered Panic?

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today